ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 64 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $195 | -69.1% | 122,676 | -86.1% | 0.02% | -69.4% |
| Q1 2023 | $631 | +31.2% | 879,684 | +5.9% | 0.06% | +3.3% |
| Q4 2022 | $481 | -99.4% | 830,829 | +950.7% | 0.06% | +500.0% |
| Q3 2022 | $75,000 | -85.5% | 79,076 | -80.0% | 0.01% | -85.7% |
| Q1 2022 | $518,000 | -43.6% | 395,585 | -24.3% | 0.07% | -39.1% |
| Q4 2021 | $919,000 | +665.8% | 522,284 | +4378.9% | 0.12% | +475.0% |
| Q3 2020 | $120,000 | -36.2% | 11,661 | -28.4% | 0.02% | -9.1% |
| Q4 2019 | $188,000 | +108.9% | 16,278 | +10.0% | 0.02% | +340.0% |
| Q3 2018 | $90,000 | – | 14,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 3,915,000 | $5,872,500 | 5.39% |
| Versant Venture Management, LLC | 5,068,233 | $7,602,350 | 4.04% |
| Sonic GP LLC | 2,000,000 | $3,000,000 | 2.91% |
| COMMODORE CAPITAL LP | 10,000,000 | $15,000,000 | 1.75% |
| VR Adviser, LLC | 6,573,300 | $9,859,950 | 1.04% |
| AIGH Capital Management LLC | 1,323,985 | $1,985,977 | 0.94% |
| Newtyn Management, LLC | 1,025,000 | $1,537,500 | 0.38% |
| Worth Venture Partners, LLC | 331,668 | $497,502 | 0.30% |
| Acuitas Investments, LLC | 291,169 | $436,754 | 0.26% |
| Quinn Opportunity Partners LLC | 398,298 | $597,447 | 0.08% |